Bulbar Muscle Weakness in the Setting of Therapeutic Botulinum Injections
暂无分享,去创建一个
[1] J. Sobel,et al. Making the Best of the Evidence: Toward National Clinical Guidelines for Botulism. , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] S. Cruz-Flores,et al. Black Tar Heroin Skin Popping as a Cause of Wound Botulism , 2017, Neurocritical Care.
[3] R. Strowd,et al. Head drop after botox: Electrodiagnostic evaluation of iatrogenic botulinum toxicity , 2017, Clinical Neurology and Neurosurgery.
[4] Ken P. Ehrhardt,et al. Atypical Facial Pain: a Comprehensive, Evidence-Based Review , 2017, Current Pain and Headache Reports.
[5] Chitralakshmi K. Balasubramanian,et al. Adverse Clinical Effects of Botulinum Toxin Intramuscular Injections for Spasticity , 2015, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[6] E. Yiannakopoulou. Serious and Long-Term Adverse Events Associated with the Therapeutic and Cosmetic Use of Botulinum Toxin , 2015, Pharmacology.
[7] D. Vugia,et al. Botulism from Drinking Pruno , 2009, Emerging infectious diseases.
[8] D. Teitelbaum,et al. Ultrasound-guided intrasphincteric botulinum toxin injection relieves obstructive defecation due to Hirschsprung's disease and internal anal sphincter achalasia. , 2017, Journal of pediatric surgery.
[9] A. Pérez,et al. Harwood-Nuss' Clinical Practice of Emergency Medicine , 2015 .